BioSpace News Archive

BrainStorm Cell Therapeutics Inc., a leading developer of cellular therapies for neurodegenerative diseases, announced financial results for the first quarter ended June 30, 2021 and provided a corporate update.

Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, reported financial results for second quarter 2021 and raised full year 2021 financial guidance.

Aldeyra Therapeutics, Inc., a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, reported financial results for the quarter ended June 30, 2021 and recent corporate highlights.

Strongbridge Biopharma plc, today reported financial results for the second quarter of 2021 and provided a corporate update.

InflaRx announced today financial and operating results for the three and six months ended June 30, 2021.

Vaxcyte, Inc. today announced an additional award of $3.2 million from CARB-X to advance development of VAX-A1, a novel vaccine designed to prevent infections caused by Group A Streptococcus pyogenes (Strep) bacteria.

Albireo Pharma, Inc. today provided a business update and reported financial results for the second quarter ended June 30, 2021.

Viridian Therapeutics, Inc. today announced that Jonathan Violin, Ph.D., President and Chief Executive Officer, and Barrett Katz, M.D., M.B.A., Chief Medical Officer of Viridian, will participate in a panel presentation at the Wedbush PacGrow Healthcare Virtual Conference, which is scheduled to take place on August 10-11, 2021.

9 Meters Biopharma, Inc. (NASDAQ:NMTR), today announced that the Executive Management team will participate in the Biopharma Spotlight Series: Innovation in GI Conference Call hosted by Gary Nachman and BMO Capital Markets.

Viveve Medical, Inc. today announced that it will report its second quarter 2021 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, August 12, 2021.